Drug:
Reaction: URINARY TRACT INFECTION
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26917909 |
US |
2 | |
Pain, Urinary tract infection, Granuloma, Multi-organ disorder, Haemolysis, Vaginal odour, Limb discomfort, Infection, Gait disturbance, |
||||
RAVULIZUMAB, |
||||
| 202 | 26918016 |
EU |
61 | 2 |
Diabetes mellitus, Herpes simplex, Oesophagitis, Candida infection, Urinary tract infection, Herpes simplex, |
||||
AVACOPAN, RITUXIMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ERYTHROPOIETIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, FOLIC ACID, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 203 | 26918021 |
IL |
90 | 2 |
Dyspnoea, Urinary tract infection, Oxygen saturation decreased, |
||||
| 204 | 26918174 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 205 | 26918436 |
US |
73 | 2 |
Nephrolithiasis, Urinary tract infection, |
||||
LEVOTHYROXINE SODIUM, FOLIC ACID, ERGOCALCIFEROL, TOFACITINIB, |
||||
| 206 | 26918933 |
US |
97 | 2 |
Syncope, Malaise, Dizziness, Urinary tract infection, Dehydration, |
||||
DUPILUMAB, |
||||
| 207 | 26919215 |
EU |
59 | 2 |
Deep vein thrombosis, Neuropathy peripheral, Thrombotic microangiopathy, Clostridium difficile infection, Urinary tract infection, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, BORTEZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 208 | 26920881 |
US |
72 | 2 |
Psoriasis, Urinary tract infection, |
||||
BIMEKIZUMAB, |
||||
| 209 | 26921248 |
EU |
41 | 2 |
Initial insomnia, Arrhythmia, Pruritus, Partial seizures, Erythema, Cystitis, Cytokine storm, Multiple sclerosis, Cardiac disorder, Headache, Swelling of nose, Hypoaesthesia, Pain of skin, Tachycardia, Oral candidiasis, Fatigue, Influenza like illness, B-lymphocyte count decreased, Inflammatory marker increased, Weight decreased, Muscle spasticity, Electrocardiogram abnormal, Oropharyngeal pain, Fall, Muscular weakness, Hyperacusis, Gait disturbance, Cognitive disorder, Middle insomnia, Skin burning sensation, Urinary tract infection, Pain in extremity, Off label use, Suspected off label use, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, OCRELIZUMAB, OCRELIZUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BUDESONIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TIZANIDINE HYDROCHLORIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, FOLIC ACID, DRONABINOL, LEVETIRACETAM, |
||||
| 210 | 26923644 |
81 | 1 | |
Urinary tract infection, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 211 | 26923707 |
45 | 2 | |
Ear infection, Urinary tract infection, |
||||
UPADACITINIB, |
||||
| 212 | 26909610 |
CA |
75 | 1 |
Urinary tract infection, Spinal fracture, Intentional product misuse, |
||||
FOSCARBIDOPA/FOSLEVODOPA, AMANTADINE, ALENDRONATE SODIUM, MIRTAZAPINE, LANSOPRAZOLE, |
||||
| 213 | 26909792 |
EU |
79 | 1 |
Diabetic ketoacidosis, Diabetes mellitus inadequate control, Urinary tract infection, Influenza, Hypotension, Off label use, |
||||
TACROLIMUS, TACROLIMUS, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE, BASILIXIMAB, BASILIXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 214 | 26909965 |
US |
2 | |
Diverticulitis, Upper respiratory tract infection, Urinary tract infection, Herpes zoster, Blood sodium decreased, |
||||
HYDROCHLOROTHIAZIDE, |
||||
| 215 | 26909998 |
GB |
54 | 2 |
Urinary tract infection, Sepsis, Liver function test increased, |
||||
CLADRIBINE, CLADRIBINE, |
||||
| 216 | 26910392 |
EU |
8 | 2 |
Urinary tract infection, Peritonitis, Peritoneal cloudy effluent, |
||||
| 217 | 26910521 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 218 | 26910801 |
US |
61 | 2 |
Urinary tract infection, |
||||
POMALIDOMIDE, |
||||
| 219 | 26910930 |
GB |
2 | |
Lower respiratory tract infection, Injection site erythema, Influenza like illness, Vomiting, Asthenia, Illness, Influenza, Chest discomfort, Feeling abnormal, Influenza like illness, Nausea, Palpitations, Malaise, Pyrexia, Influenza, Dizziness, Asthenia, Pain, Chest discomfort, Weight decreased, Paraesthesia, Ocular discomfort, Head discomfort, Urinary tract infection, Influenza like illness, Nausea, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 220 | 26910954 |
BR |
62 | 2 |
Urinary tract infection, Pathogen resistance, Escherichia infection, Epstein-Barr virus infection, Encephalitis, Pyelonephritis, Pneumonia klebsiella, Epstein-Barr virus infection, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, |
||||
| 221 | 26911041 |
US |
81 | 2 |
Cystitis, Urinary tract infection, |
||||
VIBEGRON, |
||||
| 222 | 26911212 |
US |
2 | |
Urinary tract infection, |
||||
TROFINETIDE, |
||||
| 223 | 26911230 |
US |
66 | 1 |
Herpes zoster, Incorrect dose administered, Hypotension, Confusional state, Fall, Urinary tract infection, Blood pressure increased, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 224 | 26911298 |
US |
74 | 2 |
Urinary tract infection, Urine odour abnormal, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, MELOXICAM, AMLODIPINE, ERGOCALCIFEROL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, DONEPEZIL HYDROCHLORIDE, POLYETHYLENE GLYCOL 3350, IRON, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, |
||||
| 225 | 26911411 |
CO |
71 | 2 |
Animal bite, Urinary tract infection, Joint swelling, |
||||
DENOSUMAB, |
||||
| 226 | 26911435 |
US |
64 | 2 |
Urinary tract infection, |
||||
VIBEGRON, MELOXICAM, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 227 | 26911618 |
CA |
1 | |
Urinary tract infection, |
||||
INCLISIRAN, INCLISIRAN, |
||||
| 228 | 26911749 |
US |
81 | |
Urinary tract infection, |
||||
| 229 | 26911806 |
US |
69 | 2 |
Urinary tract infection, |
||||
TRALOKINUMAB-LDRM, FLUTICASONE PROPIONATE, LISINOPRIL, MELOXICAM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PANTOPRAZOLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 230 | 26911919 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 231 | 26911947 |
US |
77 | 2 |
Abdominal pain, Pyrexia, Urinary tract infection, Diverticulitis, Vomiting, Cerebral haemorrhage, |
||||
INFLIXIMAB, |
||||
| 232 | 26911987 |
KR |
5 | 2 |
Urinary tract infection, |
||||
NIRSEVIMAB, |
||||
| 233 | 26912687 |
EU |
2 | |
Syncope, Atrioventricular block, Lymphoedema, Injection site bruising, Head injury, Arthralgia, Tachycardia, Cardiac pacemaker insertion, Musculoskeletal discomfort, Bone pain, Dizziness, Wound, Feeling abnormal, Injection site discomfort, Erythema, Urinary tract infection, Injection site pain, Pruritus, Pyrexia, Headache, Somnolence, Chromaturia, Rhinalgia, |
||||
ROZANOLIXIZUMAB, ROZANOLIXIZUMAB, FUROSEMIDE, ERGOCALCIFEROL, IRBESARTAN, EVOLOCUMAB, PYRIDOSTIGMINE BROMIDE, |
||||
| 234 | 26913181 |
EU |
||
Hepatotoxicity, Rash maculo-papular, Hypothyroidism, Colitis, Pneumonitis, Alanine aminotransferase increased, Blood alkaline phosphatase increased, Hypersensitivity, Anaemia, Anorectal infection, Aspartate aminotransferase increased, Blood bilirubin increased, Cholangitis, Colitis, Diarrhoea, Fatigue, Dyspnoea, Febrile neutropenia, Gastritis, Hepatotoxicity, Hypertension, Kidney infection, Kidney infection, Pneumonia, Neuralgia, Neutrophil count decreased, Platelet count decreased, Psychotic disorder, Sepsis, Embolism, Urinary fistula, Urinary tract infection, Uterine infection, Vaginal haemorrhage, Arthritis, Blood corticotrophin decreased, Blood prolactin abnormal, Vision blurred, Blood creatinine increased, Diabetes mellitus, Dry eye, Oesophageal infection, Pyrexia, Gamma-glutamyltransferase increased, Headache, Hyperglycaemia, Hyperthyroidism, Hypomagnesaemia, Hypophysitis, Pain, Peripheral sensory neuropathy, Pharyngitis, Proteinuria, Pruritus, Renal disorder, Urinary tract disorder, Skin disorder, Blood thyroid stimulating hormone increased, |
||||
ATEZOLIZUMAB, ATEZOLIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 235 | 26913349 |
74 | 1 | |
Urinary tract infection, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 236 | 26913388 |
1 | ||
Urinary tract infection, |
||||
SELPERCATINIB, |
||||
| 237 | 26913438 |
CA |
9 | 2 |
Stoma site abscess, Condition aggravated, Treatment failure, Urinary tract infection, Mouth ulceration, Off label use, Hordeolum, |
||||
CANAKINUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, COLCHICINE, COLCHICINE, COLCHICINE, COLCHICINE, COLCHICINE, COLCHICINE, COLCHICINE, COLCHICINE, COLCHICINE, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, GABAPENTIN, HYDROCHLOROTHIAZIDE, LANSOPRAZOLE, |
||||
| 238 | 26913612 |
US |
94 | 2 |
Confusional state, Hallucination, Feeling abnormal, Urinary tract infection, Herpes zoster, Blister, Fatigue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 239 | 26913690 |
US |
77 | |
Urinary tract infection, Pulmonary congestion, Nasal congestion, Epistaxis, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 240 | 26913870 |
US |
2 | |
Urinary tract infection, |
||||
SIBEPRENLIMAB, |
||||
| 241 | 26913968 |
BR |
2 | |
Urinary tract infection, |
||||
TIRZEPATIDE, |
||||
| 242 | 26916653 |
56 | 2 | |
Urinary tract infection, Pyrexia, |
||||
| 243 | 26917241 |
72 | 2 | |
Urinary tract infection, Therapy cessation, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 244 | 26917242 |
75 | 2 | |
Urinary tract infection, COVID-19, Pulmonary thrombosis, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 245 | 26918100 |
64 | 2 | |
Back pain, Urinary tract infection, |
||||
ENCORAFENIB, BINIMETINIB, |
||||
| 246 | 26919313 |
84 | 2 | |
Decreased appetite, Urinary tract infection, |
||||
TAFAMIDIS, |
||||
| 247 | 26904769 |
US |
80 | 1 |
Mental status changes, Urinary tract infection, |
||||
APOMORPHINE HYDROCHLORIDE, |
||||
| 248 | 26905061 |
US |
71 | 2 |
Lactic acidosis, Urinary tract infection, Sepsis, Pyelonephritis, |
||||
LENALIDOMIDE, |
||||
| 249 | 26905461 |
US |
29 | |
Arthralgia, Bone pain, Myalgia, Pain, Headache, Urinary tract infection, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 250 | 26905548 |
US |
84 | 2 |
Fall, Head injury, Musculoskeletal disorder, Urinary tract infection, |
||||
EVOLOCUMAB, |
||||
| 251 | 26905718 |
TW |
74 | 2 |
Blood osmolarity decreased, Hyponatraemia, Urinary tract infection, Sepsis, Inflammatory marker increased, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 252 | 26905950 |
US |
2 | |
Urinary tract infection, |
||||
GOLIMUMAB, |
||||
| 253 | 26906177 |
GB |
76 | 2 |
Hypervolaemia, Asthenia, Urinary tract infection, Fall, Radius fracture, Product use issue, |
||||
MOMELOTINIB, MOMELOTINIB, HYDROXYUREA, |
||||
| 254 | 26906300 |
US |
2 | |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 255 | 26906561 |
US |
||
Oxygen saturation decreased, Urinary tract infection, |
||||
AMBRISENTAN, |
||||
| 256 | 26906598 |
US |
2 | |
Hallucination, Urinary tract infection, |
||||
PIMAVANSERIN TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 257 | 26907244 |
EU |
59 | 2 |
Urinary tract infection, Pain in extremity, Blood glucose increased, |
||||
PEGFILGRASTIM, |
||||
| 258 | 26907310 |
US |
68 | 1 |
Crohn^s disease, Humidity intolerance, Urinary tract infection, Escherichia infection, Sepsis, Diarrhoea, Vomiting, |
||||
UPADACITINIB, |
||||
| 259 | 26907752 |
CN |
54 | 2 |
Myelosuppression, Platelet count decreased, Bacteraemia, Urinary tract infection, Nausea, Vomiting, |
||||
BEVACIZUMAB, CISPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 260 | 26907942 |
US |
65 | 2 |
Tremor, Urinary tract infection, Freezing phenomenon, Blood glucose abnormal, |
||||
UPADACITINIB, |
||||
| 261 | 26907973 |
US |
2 | |
Urinary tract infection, Muscle spasms, Tinnitus, |
||||
TEPROTUMUMAB, |
||||
| 262 | 26908088 |
EU |
63 | 1 |
Urinary tract infection, Genital infection, Phimosis, Urinary tract infection, Thirst, Nocturia, Confusional state, Intentional product use issue, |
||||
EMPAGLIFLOZIN, LANSOPRAZOLE, BISOPROLOL FUMARATE, |
||||
| 263 | 26908244 |
US |
66 | 2 |
Dyspnoea, Rash, Haemoglobin decreased, Dizziness, Urticaria, Abdominal discomfort, Nausea, Vomiting, Diarrhoea, Decreased appetite, Urinary tract infection, Fatigue, Intentional product misuse, |
||||
CAPIVASERTIB, ASCORBIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 264 | 26909016 |
EU |
1 | |
Psoriatic arthropathy, Urinary tract infection, Upper respiratory tract infection, |
||||
BIMEKIZUMAB, |
||||
| 265 | 26909072 |
JP |
||
Sepsis, Urinary tract infection, |
||||
EMPAGLIFLOZIN, |
||||
| 266 | 26909088 |
US |
2 | |
Urinary tract infection, Illness, |
||||
DAPAGLIFLOZIN, |
||||
| 267 | 26909418 |
US |
25 | |
Vomiting, Systolic hypertension, Nausea, Urinary tract infection, |
||||
DROXIDOPA, |
||||
| 268 | 26912282 |
1 | ||
Urinary tract infection, |
||||
PIRTOBRUTINIB, |
||||
| 269 | 26912815 |
2 | ||
Urinary tract infection, |
||||
TEPOTINIB HYDROCHLORIDE, CLONAZEPAM, |
||||
| 270 | 26912823 |
2 | ||
Urinary tract infection, Loss of personal independence in daily activities, Pain, Injection site reaction, |
||||
ADALIMUMAB-RYVK, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE, NORGESTIMATE AND ETHINYL ESTRADIOL, ERGOCALCIFEROL, |
||||
| 271 | 26918762 |
71 | 1 | |
Urinary tract infection, Sepsis, Bladder neoplasm surgery, Intentional dose omission, Immunosuppression, |
||||
ADALIMUMAB, |
||||
| 272 | 26918860 |
63 | 2 | |
Urinary tract infection, Symptom recurrence, Fall, Back pain, |
||||
TERIFLUNOMIDE, |
||||
| 273 | 26903749 |
US |
30 | 2 |
COVID-19, Constipation, Restless legs syndrome, Gastrooesophageal reflux disease, Nausea, Fall, Urinary tract infection, Sciatica, Blood pressure increased, Morning sickness, Exposure during pregnancy, |
||||
BELIMUMAB, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, HYDROXYCHLOROQUINE, SUMATRIPTAN, |
||||
| 274 | 26903869 |
US |
60 | 2 |
Kidney infection, Sepsis, Urinary tract infection, Sleep disorder due to a general medical condition, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 275 | 26903920 |
US |
52 | 2 |
Pyrexia, Product dose omission issue, Urinary tract infection, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 276 | 26904180 |
US |
73 | 2 |
Urinary tract infection, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 277 | 26904482 |
US |
2 | |
Pneumonia, Urinary tract infection, |
||||
SECUKINUMAB, |
||||
| 278 | 26902709 |
US |
52 | 2 |
Endometrial cancer, Urinary tract infection, Hysterectomy, Urinary tract infection, |
||||
RISANKIZUMAB-RZAA, |
||||
| 279 | 26902876 |
US |
70 | 2 |
Myasthenia gravis, Urinary tract infection, |
||||
NIPOCALIMAB-AAHU, |
||||
| 280 | 26903030 |
GB |
46 | 1 |
Urinary tract infection, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NIRMATRELVIR AND RITONAVIR, |
||||
| 281 | 26903096 |
GB |
61 | 2 |
Knee arthroplasty, Urinary tract infection, |
||||
ETANERCEPT, |
||||
| 282 | 26903127 |
CA |
46 | |
Musculoskeletal stiffness, Tenderness, Psoriasis, Infection, Urinary tract infection, Skin infection, Ear infection, Intentional dose omission, Intentional product use issue, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, IRBESARTAN, HYDROCHLOROTHIAZIDE, PERINDOPRIL ERBUMINE, |
||||
| 283 | 26903339 |
US |
90 | 2 |
Urinary tract infection, Oxygen saturation decreased, Malaise, Device issue, Device power source issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, MELATONIN, ERGOCALCIFEROL, OXYGEN, 0XYGEN, PREDNISONE, FUROSEMIDE, |
||||
| 284 | 26903448 |
GB |
61 | 2 |
Urinary tract infection, Abdominal mass, |
||||
SIPONIMOD, |
||||
| 285 | 26897770 |
US |
2 | |
Nephropathy toxic, Urinary tract infection, |
||||
| 286 | 26898025 |
GB |
2 | |
Syncope, Urinary tract infection, Weight decreased, Tremor, Vomiting, Hypotension, Memory impairment, |
||||
OCRELIZUMAB, OCRELIZUMAB, |
||||
| 287 | 26898085 |
US |
84 | 1 |
Nephrolithiasis, Urinary tract infection, Respiratory tract congestion, |
||||
RELUGOLIX, RELUGOLIX, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, EZETIMIBE, ASPIRIN, INSULIN GLARGINE, GABAPENTIN, ACETYLCYSTEINE, DAROLUTAMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CALCIUM, LOSARTAN, BACLOFEN, FISH OIL, MAGNESIUM, ERGOCALCIFEROL, |
||||
| 288 | 26898147 |
CO |
67 | 2 |
Brain neoplasm, Urinary tract infection, |
||||
DENOSUMAB, |
||||
| 289 | 26898261 |
US |
21 | 2 |
Malaise, Fatigue, Scarlet fever, Pyrexia, Pyelonephritis, Urinary tract infection, Myalgia, Anxiety, Metabolic acidosis, Hypomagnesaemia, Hyperparathyroidism secondary, Essential hypertension, Pulmonary hypertension, IgA nephropathy, Complications of transplanted kidney, Blood glucose increased, Mean cell haemoglobin decreased, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CINACALCET, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 290 | 26898305 |
US |
73 | 2 |
Urinary tract infection, Decreased appetite, Flatulence, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, QUETIAPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, BUPROPION, BREXPIPRAZOLE, |
||||
| 291 | 26898383 |
US |
59 | 1 |
Urinary tract infection, |
||||
LENALIDOMIDE, |
||||
| 292 | 26898435 |
US |
39 | 1 |
Urinary tract infection, Immune system disorder, |
||||
DUPILUMAB, |
||||
| 293 | 26898502 |
US |
80 | |
Urinary tract infection, Acute kidney injury, Therapy interrupted, Mobility decreased, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 294 | 26898543 |
US |
2 | |
Escherichia bacteraemia, Urinary tract infection, Drug interaction, |
||||
LEVOTHYROXINE SODIUM, |
||||
| 295 | 26898918 |
JP |
38 | 2 |
Malacoplakia, Klebsiella bacteraemia, Urinary tract infection, Acute kidney injury, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 296 | 26898984 |
CA |
83 | 1 |
Delirium, On and off phenomenon, Asthenia, Musculoskeletal stiffness, Confusional state, Hallucinations, mixed, Underdose, Speech disorder, Incontinence, Device issue, Freezing phenomenon, Trismus, Psychotic disorder, Urinary tract infection, Pneumonia, Agitation, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, APIXABAN, PANTOPRAZOLE, DUTASTERIDE, AMANTADINE, SENNOSIDES, ERGOCALCIFEROL, MIRTAZAPINE, |
||||
| 297 | 26898994 |
US |
2 | |
Kidney infection, Injection site pain, Urinary tract infection, Haematological infection, |
||||
RISANKIZUMAB-RZAA, |
||||
| 298 | 26899003 |
GB |
2 | |
Dysuria, Urinary tract infection, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METRONIDAZOLE, METRONIDAZOLE TOPICAL, CLARITHROMYCIN, LANSOPRAZOLE, |
||||
| 299 | 26899091 |
CA |
32 | 2 |
Pneumonia, Nasal congestion, Infection, Sinusitis, Sleep disorder due to a general medical condition, Vertigo, Urticaria, Vomiting, Rhinitis, Therapeutic product effect decreased, Nasopharyngitis, Decreased activity, Oropharyngeal pain, Stress, Dyspnoea exertional, Eczema, Feeding disorder, Psoriasis, Dizziness, Full blood count abnormal, Pain, Cough, Diarrhoea, Influenza, Tooth abscess, Ear infection, Drug ineffective, Product administration error, Asthma, Middle insomnia, Abdominal pain, Loss of personal independence in daily activities, Upper-airway cough syndrome, Wheezing, Productive cough, Migraine, Therapeutic response decreased, Blood pressure increased, Eosinophil count abnormal, Bacterial infection, Terminal insomnia, Dyspnoea, Anxiety, Fungal infection, Urinary tract infection, Musculoskeletal chest pain, Restrictive pulmonary disease, Nasal discharge discolouration, Emphysema, Forced expiratory volume decreased, Rales, Malaise, Tachycardia, Heart rate increased, Sleep disorder, Obstructive airways disorder, |
||||
FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMALIZUMAB, |
||||
| 300 | 26899255 |
CA |
45 | 2 |
Hyponatraemia, Vomiting, Discoloured vomit, Hallucination, Delirium, Pneumonia, Gait disturbance, Asthenia, Pyrexia, Diarrhoea, Abdominal distension, Musculoskeletal chest pain, Dysuria, Pruritus genital, Nausea, Lethargy, Confusional state, Dehydration, Electrolyte depletion, Urinary tract infection, Electrolyte imbalance, |
||||
PREDNISONE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30